Alalevonadifloxacin (mesylate)

Alalevonadifloxacin (WCK-2349) mesylate is an orally active antibiotic targeting Gram-positive and Gram-negative bacteria. Alalevonadifloxacin mesylate is promising for research of acute bacterial skin and skin structure infections and hospital-acquired pneumonia caused by MRSA and other pathogens[1].

Product Specifications

CAS Number

[948895-94-1]

Product Name Alternative

WCK-2349 (mesylate)

UNSPSC

12352005

Target

Antibiotic; Bacterial

Related Pathways

Anti-infection

Field of Research

Infection

Smiles

C[C@H]1CCC2=C(N3CCC(OC([C@@H](N)C)=O)CC3)C(F)=CC4=C2N1C=C(C(O)=O)C4=O.CS(=O)(O)=O

Molecular Formula

C23H30FN3O8S

Molecular Weight

527.56

References & Citations

[1]Mason JW, et al. Electrocardiographic Effects of a Supratherapeutic Dose of WCK 2349, a Benzoquinolizine Fluoroquinolone. Clin Transl Sci. 2019 Jan;12 (1) :47-52.